Single-dose treatment transformed lives of patients with potentially deadly condition in first human trial
A groundbreaking gene therapy has been hailed as a “medical magic wand” after the treatment transformed the lives of patients with a hereditary disorder that causes painful and potentially fatal swelling.
Patients who took part in the first human trial of the therapy experienced a dramatic improvement in their symptoms, and many were able to come off long-term medication and return to life as normal.
About Author
More Stories
Male mosquitoes to be genetically engineered to poison females with semen in Australian research
Breakthrough drugs herald ‘new era’ in battle against dementia, experts predict
Memo to Trump: US telecoms is vulnerable to hackers. Please hang up and try again | John Naughton